Development of a new supplementary diagnostic method for endometrial cancer by flow cytometry employing anti-endometrial cancer antibody, MSN-1 and MSN-3

K. Tsukazaki, K. Kobiki, K. Hasegawa, M. Sakayori, S. Nozawa

Research output: Contribution to journalArticle

Abstract

In cytology, it is often difficult to make a definite diagnosis of endometrial cancer. In order to devise a new supplementary method, using flow cytometry we analyzed the reactivities of endometrial cells with two monoclonal antibodies (MSN-1 and MSN-3), both of which are strongly reactive to endometrial cancer cells. Employing either or both antibodies in flow cytometry, we investigated the usefulness of this analysis for distinguishing endometrial cancer cells from normal endometrial cells. Results revealed a low positive rate for normal endometrium: 9.2% with MSN-1 and 5.0% with MSN-3. In contrast, for endometrial cancer the positive rate was high: 81.2% with MSN-1 and 43.8% with MSN-3. Combined analysis with both antibodies increased the positive rate for endometrial cancer to 93.7%. These results suggest that analysis by flow cytometry employing MSN-1 and MSN-3 may have a diagnostic value for endometrial cancer. We are also investigating the usefulness of two-color analysis using these antibodies.

Original languageEnglish
Pages (from-to)2476-2483
Number of pages8
JournalNippon rinsho. Japanese journal of clinical medicine
Volume50
Issue number10
Publication statusPublished - 1992 Oct

Fingerprint

Endometrial Neoplasms
Flow Cytometry
Antibodies
Endometrium
Cell Biology
Color
Monoclonal Antibodies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Development of a new supplementary diagnostic method for endometrial cancer by flow cytometry employing anti-endometrial cancer antibody, MSN-1 and MSN-3. / Tsukazaki, K.; Kobiki, K.; Hasegawa, K.; Sakayori, M.; Nozawa, S.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 50, No. 10, 10.1992, p. 2476-2483.

Research output: Contribution to journalArticle

@article{8767b861bc5147f78964d43d0575efde,
title = "Development of a new supplementary diagnostic method for endometrial cancer by flow cytometry employing anti-endometrial cancer antibody, MSN-1 and MSN-3",
abstract = "In cytology, it is often difficult to make a definite diagnosis of endometrial cancer. In order to devise a new supplementary method, using flow cytometry we analyzed the reactivities of endometrial cells with two monoclonal antibodies (MSN-1 and MSN-3), both of which are strongly reactive to endometrial cancer cells. Employing either or both antibodies in flow cytometry, we investigated the usefulness of this analysis for distinguishing endometrial cancer cells from normal endometrial cells. Results revealed a low positive rate for normal endometrium: 9.2{\%} with MSN-1 and 5.0{\%} with MSN-3. In contrast, for endometrial cancer the positive rate was high: 81.2{\%} with MSN-1 and 43.8{\%} with MSN-3. Combined analysis with both antibodies increased the positive rate for endometrial cancer to 93.7{\%}. These results suggest that analysis by flow cytometry employing MSN-1 and MSN-3 may have a diagnostic value for endometrial cancer. We are also investigating the usefulness of two-color analysis using these antibodies.",
author = "K. Tsukazaki and K. Kobiki and K. Hasegawa and M. Sakayori and S. Nozawa",
year = "1992",
month = "10",
language = "English",
volume = "50",
pages = "2476--2483",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "10",

}

TY - JOUR

T1 - Development of a new supplementary diagnostic method for endometrial cancer by flow cytometry employing anti-endometrial cancer antibody, MSN-1 and MSN-3

AU - Tsukazaki, K.

AU - Kobiki, K.

AU - Hasegawa, K.

AU - Sakayori, M.

AU - Nozawa, S.

PY - 1992/10

Y1 - 1992/10

N2 - In cytology, it is often difficult to make a definite diagnosis of endometrial cancer. In order to devise a new supplementary method, using flow cytometry we analyzed the reactivities of endometrial cells with two monoclonal antibodies (MSN-1 and MSN-3), both of which are strongly reactive to endometrial cancer cells. Employing either or both antibodies in flow cytometry, we investigated the usefulness of this analysis for distinguishing endometrial cancer cells from normal endometrial cells. Results revealed a low positive rate for normal endometrium: 9.2% with MSN-1 and 5.0% with MSN-3. In contrast, for endometrial cancer the positive rate was high: 81.2% with MSN-1 and 43.8% with MSN-3. Combined analysis with both antibodies increased the positive rate for endometrial cancer to 93.7%. These results suggest that analysis by flow cytometry employing MSN-1 and MSN-3 may have a diagnostic value for endometrial cancer. We are also investigating the usefulness of two-color analysis using these antibodies.

AB - In cytology, it is often difficult to make a definite diagnosis of endometrial cancer. In order to devise a new supplementary method, using flow cytometry we analyzed the reactivities of endometrial cells with two monoclonal antibodies (MSN-1 and MSN-3), both of which are strongly reactive to endometrial cancer cells. Employing either or both antibodies in flow cytometry, we investigated the usefulness of this analysis for distinguishing endometrial cancer cells from normal endometrial cells. Results revealed a low positive rate for normal endometrium: 9.2% with MSN-1 and 5.0% with MSN-3. In contrast, for endometrial cancer the positive rate was high: 81.2% with MSN-1 and 43.8% with MSN-3. Combined analysis with both antibodies increased the positive rate for endometrial cancer to 93.7%. These results suggest that analysis by flow cytometry employing MSN-1 and MSN-3 may have a diagnostic value for endometrial cancer. We are also investigating the usefulness of two-color analysis using these antibodies.

UR - http://www.scopus.com/inward/record.url?scp=0026939040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026939040&partnerID=8YFLogxK

M3 - Article

C2 - 1280307

AN - SCOPUS:0026939040

VL - 50

SP - 2476

EP - 2483

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 10

ER -